BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr |
Equity - Authorised | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Equity - Issued | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr |
Equity Paid Up | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr | ₹43 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹45 Cr | ₹62 Cr | ₹-9.14 Cr | ₹-23 Cr | ₹-13 Cr |
Securities Premium | - | - | - | - | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹-66 Cr | ₹-50 Cr | ₹-41 Cr | ₹-23 Cr | ₹-13 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹111 Cr | ₹112 Cr | ₹32 Cr | - | - |
Reserve excluding Revaluation Reserve | ₹-66 Cr | ₹-50 Cr | ₹-41 Cr | ₹-23 Cr | ₹-13 Cr |
Revaluation reserve | ₹111 Cr | ₹112 Cr | ₹32 Cr | - | - |
Shareholder's Funds | ₹88 Cr | ₹105 Cr | ₹34 Cr | ₹20 Cr | ₹31 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-27 Cr | ₹-21 Cr | ₹-20 Cr | ₹-14 Cr | ₹-10 Cr |
Deferred Tax Assets | ₹27 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr | ₹10 Cr |
Deferred Tax Liability | - | - | ₹0.27 Cr | ₹0.23 Cr | ₹0.19 Cr |
Other Long Term Liabilities | - | - | - | - | ₹0.48 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹6.39 Cr | ₹6.11 Cr | ₹5.85 Cr | ₹5.65 Cr | ₹5.33 Cr |
Total Non-Current Liabilities | ₹-20 Cr | ₹-15 Cr | ₹-14 Cr | ₹-8.35 Cr | ₹-4.20 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹1.03 Cr | ₹0.87 Cr | ₹15 Cr | ₹44 Cr | ₹44 Cr |
Sundry Creditors | ₹1.03 Cr | ₹0.87 Cr | ₹15 Cr | ₹44 Cr | ₹44 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹16 Cr | ₹17 Cr | ₹18 Cr | ₹53 Cr | ₹11 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | ₹2.88 Cr | ₹38 Cr | ₹0.05 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹16 Cr | ₹17 Cr | ₹15 Cr | ₹15 Cr | ₹11 Cr |
Short Term Borrowings | ₹70 Cr | ₹78 Cr | ₹27 Cr | ₹3.04 Cr | ₹32 Cr |
Secured ST Loans repayable on Demands | ₹70 Cr | ₹78 Cr | ₹27 Cr | ₹3.04 Cr | ₹32 Cr |
Working Capital Loans- Sec | ₹70 Cr | ₹78 Cr | ₹27 Cr | ₹3.04 Cr | ₹32 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-70 Cr | ₹-78 Cr | ₹-27 Cr | ₹-3.04 Cr | ₹-32 Cr |
Short Term Provisions | ₹6.86 Cr | ₹5.35 Cr | ₹4.42 Cr | ₹0.88 Cr | ₹0.80 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | ₹6.00 Cr | ₹5.35 Cr | ₹4.42 Cr | ₹0.88 Cr | ₹0.80 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.85 Cr | - | - | - | - |
Total Current Liabilities | ₹94 Cr | ₹101 Cr | ₹64 Cr | ₹101 Cr | ₹88 Cr |
Total Liabilities | ₹162 Cr | ₹192 Cr | ₹84 Cr | ₹113 Cr | ₹115 Cr |
ASSETS | |||||
Gross Block | ₹157 Cr | ₹158 Cr | ₹46 Cr | ₹46 Cr | ₹5.97 Cr |
Less: Accumulated Depreciation | ₹41 Cr | ₹42 Cr | ₹41 Cr | ₹41 Cr | ₹1.27 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹116 Cr | ₹116 Cr | ₹4.23 Cr | ₹4.47 Cr | ₹4.70 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | ₹32 Cr | ₹0.22 Cr | ₹0.22 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹1.16 Cr | ₹1.23 Cr | ₹1.29 Cr | ₹1.50 Cr | ₹1.80 Cr |
Other Non Current Assets | ₹9.28 Cr | ₹9.06 Cr | ₹13 Cr | ₹14 Cr | ₹9.50 Cr |
Total Non-Current Assets | ₹126 Cr | ₹126 Cr | ₹50 Cr | ₹20 Cr | ₹16 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹1.42 Cr | ₹36 Cr | ₹13 Cr | ₹52 Cr | ₹14 Cr |
Raw Materials | ₹0.26 Cr | ₹27 Cr | ₹6.29 Cr | ₹22 Cr | ₹0.01 Cr |
Work-in Progress | - | - | - | - | - |
Finished Goods | - | ₹5.95 Cr | ₹6.40 Cr | ₹27 Cr | ₹14 Cr |
Packing Materials | ₹0.83 Cr | ₹2.99 Cr | ₹0.56 Cr | ₹3.21 Cr | ₹0.73 Cr |
Stores  and Spare | ₹0.33 Cr | ₹0.32 Cr | ₹0.25 Cr | ₹0.23 Cr | ₹0.15 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹14 Cr | ₹1.13 Cr | ₹0.01 Cr | ₹18 Cr | ₹73 Cr |
Debtors more than Six months | ₹14 Cr | ₹1.11 Cr | ₹0.00 Cr | ₹6.45 Cr | ₹6.45 Cr |
Debtors Others | - | ₹0.02 Cr | ₹0.01 Cr | ₹11 Cr | ₹67 Cr |
Cash and Bank | ₹8.74 Cr | ₹13 Cr | ₹11 Cr | ₹12 Cr | ₹7.93 Cr |
Cash in hand | - | - | - | - | - |
Balances at Bank | ₹8.74 Cr | ₹13 Cr | ₹11 Cr | ₹12 Cr | ₹7.93 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹3.95 Cr | ₹3.41 Cr | ₹2.92 Cr | ₹1.19 Cr | ₹0.46 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹1.16 Cr | ₹0.62 Cr | ₹0.78 Cr | ₹1.19 Cr | ₹0.45 Cr |
Prepaid Expenses | ₹0.01 Cr | ₹0.17 Cr | - | ₹0.00 Cr | ₹0.00 Cr |
Other current_assets | ₹2.78 Cr | ₹2.62 Cr | ₹2.14 Cr | - | - |
Short Term Loans and Advances | ₹7.81 Cr | ₹12 Cr | ₹6.99 Cr | ₹10 Cr | ₹2.94 Cr |
Advances recoverable in cash or in kind | ₹0.67 Cr | ₹0.75 Cr | ₹0.10 Cr | ₹0.06 Cr | ₹0.29 Cr |
Advance income tax and TDS | ₹7.14 Cr | ₹11 Cr | ₹6.89 Cr | ₹10 Cr | ₹2.66 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | - | - | - | ₹0.15 Cr | ₹0.00 Cr |
Total Current Assets | ₹36 Cr | ₹65 Cr | ₹34 Cr | ₹93 Cr | ₹99 Cr |
Net Current Assets (Including Current Investments) | ₹-58 Cr | ₹-36 Cr | ₹-30 Cr | ₹-7.69 Cr | ₹10 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹162 Cr | ₹192 Cr | ₹84 Cr | ₹113 Cr | ₹115 Cr |
Contingent Liabilities | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr |
Total Debt | ₹70 Cr | ₹78 Cr | ₹27 Cr | ₹3.04 Cr | ₹32 Cr |
Book Value | -5.33 | -1.48 | 0.55 | 4.74 | 7.10 |
Adjusted Book Value | -5.33 | -1.48 | 0.55 | 4.74 | 7.10 |
Compare Balance Sheet of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹102.7 Cr | -4.2% | -9.9% | -3.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹425,930.0 Cr | -1.4% | -7.1% | 48% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 1.5% | -2.1% | 63% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -3.5% | -5.2% | 18% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -3.9% | -10.1% | 10.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,280.3 Cr | -0.3% | -7.3% | 52.2% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -4.2% |
-9.9% |
-3.7% |
SENSEX | -2.4% |
-4.2% |
19.5% |
You may also like the below Video Courses